Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services

 
back
11 Eye
11-06 Beta-blockers

Levobunolol Betagan
Formulary
  • Eye drops, levobunolol hydrochloride 0.5%, polyvinyl alcohol (Liquifilm®) 1.4%
  • Single use eye drops, levobunolol hydrochloride 0.5%, polyvinyl alcohol (Liquifilm®) 1.4%

 

Note:  Consultant initiation only


Amber 2 View adult BNF  View SPC online  View childrens BNF
Timolol
Formulary

Eye drops 0.25%, 0.5%

Once daily preparations:    

  • Timoptol-LA® (Amber 2) Timolol maleate ophthalmic gel-forming solution 0.25%, 0.5%
  • Tiopex® (Amber 2) timolol maleate 0.1% eye gel in unit doses. 

Notes:

  • The once daily preparations are Consultant initiation only
    • Prescribers are reminded that the Timoptol-LA® and Tiopex® are to be used once daily
    • There is no evidence to show that 0.5% timolol is any more effective than 0.25%. The lower strength may minimise the risk of systemic side effects.
    • Systemic absorption may follow topical application; therefore eye drops containing a beta-blocker are contra-indicated in patients with bradycardia, heart block or uncontrolled heart failure.
    • CSM advice: The CSM has advised that beta-blockers, even those with apparent cardio-selectivity, should not be used in patients with asthma or obstructive airways disease, unless no alternative treatment is available. In such cases the risk of inducing bronchospasm should be appreciated and appropriate precautions taken.
    • Beta-blocker eye drops should be avoided in patients receiving oral verapamil.

Green View adult BNF  View SPC online  View childrens BNF
Timolol Once-daily
Formulary
  • Timoptol-LA® (Amber 2) Timolol maleate ophthalmic gel-forming solution 0.25%, 0.5%
  • Tiopex® (Amber 2) timolol maleate 0.1% eye gel in unit doses. 

Notes:

  • The once daily preparations are Consultant initiation only
    • Prescribers are reminded that the Timoptol-LA® and Tiopex® are to be used once daily
    • There is no evidence to show that 0.5% timolol is any more effective than 0.25%. The lower strength may minimise the risk of systemic side effects.
    • Systemic absorption may follow topical application; therefore eye drops containing a beta-blocker are contra-indicated in patients with bradycardia, heart block or uncontrolled heart failure.
    • CSM advice: The CSM has advised that beta-blockers, even those with apparent cardio-selectivity, should not be used in patients with asthma or obstructive airways disease, unless no alternative treatment is available. In such cases the risk of inducing bronchospasm should be appreciated and appropriate precautions taken.
    • Beta-blocker eye drops should be avoided in patients receiving oral verapamil.

Amber 2 View adult BNF  View SPC online  View childrens BNF
Betaxolol Betoptic®
Non Formulary

Eye drops 0.25%, 0.5%


Amber 1 View adult BNF  View SPC online  View childrens BNF
Carteolol Teoptic®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Metipranolol Minims® Metipranolol
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Timolol Once-daily Nyogel®
Non Formulary

View adult BNF  View SPC online  View childrens BNF